Abstract
This study was conducted to investigate the molecular epidemiology of resistance in
Acinetobacter baumannii
isolates collected at a hospital in Riyadh, Saudi Arabia, from January through December 2010. Twenty-seven
A. baumannii
were highly resistant (MIC
90
> 256 μg/ml) to ceftazidime, cefepime, and aztreonam. Imipenem resistance was seen in 24 isolates, of which 18 had an minimum inhibitory concentration (MIC) >32 μg/mL. Ciprofloxacin, gentamicin, and amikacin resistance was found in 93%, 52%, and 37% of all the isolates, respectively. Moreover, 8 (30%) isolates showed colistin resistance, and 15 (56%) were found to have MICs ≥4 μg/mL for tigecycline. The frequency of ADC, GES-1, GES-11, and GES-5 were 96.3% (
n
= 26), 18.5% (
n
= 5), 11% (
n
= 3), and 3.7% (
n
= 1), respectively. OXA-23 was found in 63% (
n
= 17) of the isolates; IS
Aba1
was found upstream of OXA-23 in 16. OXA-24/40 was detected in only one strain. Multilocus sequence typing (MLST) and pulsed-field gel electrophoresis (PFGE) analysis revealed that the 27 strains were distributed in 8 sequence types (STs) and 16 clonal pulsotypes (A-P). Five singleton STs were identified, including ST15 and ST113–ST116. The emergence of multidrug-resistant
A. baumannii
is becoming a major concern in Saudi Arabia. Metallo-β-lactamases have no role in carbapenem resistance in this collection. The spread of OXA-23 in our strains occurred across different STs and pulsotypes, unlike what has been observed in many other countries. PFGE typing was more discriminatory than MLST. The high frequency of colistin and tigecycline resistance found in the isolates calls for continuous monitoring. This study describes the first identification of GES-5 conferring carbapenem resistance in
A. baumannii
.